Click it and Unblock the Notifications
Latest Updates
-
Horoscope for Today April 06, 2026 - Practical Steps Bring Calm Progress -
Chana Masala Recipe: Experience Dhaba Style Authentic Taste -
Struggling With Oily Skin This Summer? Simple Tips to Keep Shine Under Control -
Garlic Bread Recipe: The Cheesy Bakery Style Trick You Need -
Soha Ali Khan Swears By This ‘Gentle Game-Changer’ Lemon Drink for Gut Health: Full Recipe Inside -
World Health Day 2026: You’re Not As Healthy As You Think—Here’s Why -
One Pot Easy Lunch Recipe: Flavorful Veg Pulao -
Karan Aujla India Tour Controversy: Lucknow and Ludhiana Shows Cancelled—What Went Wrong? -
Kissing Disease Linked to 3x Higher Risk of Multiple Sclerosis: What You Should Know -
Feeling Drained in the Heat? 10 Healthy Drinks to Sip This Summer
Potential Therapeutic Targets For Cystic Fibrosis
Cystic Fibrosis is the condition which leads to the progressive disorders in the functioning of lungs and pancreas. It may also cause gastrointestinal obstruction or blockage. The defective signalling of a protein, called Peroxisome Proliferator Activated Receptor (ppar) causes the severity of cystic fibrosis.
So the symptoms of the disease can be reduced to an extent, if the defective signalling of ppar is corrected.
The research also reveals that the defect in the signalling of ppar is resulted by the reduced levels of prostaglandins which activate the receptor. The studies are done by the scientists from San Diego School of Medicine affiliated to the University of California.
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.
Continue with Google